ACASTI PHARMA INC (ACST) Stock Analyst Ratings
NASDAQ:ACST - Nasdaq - CA00430K8656 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to ACST. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.16. This target is 142.14% above the current price.
ACST was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ACST.
In the previous month the buy percentage consensus was at a similar level.
ACST was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-09-26 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-09-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-07 | Craig-Hallum | Initiate | Buy |
| 2023-02-15 | EF Hutton | Reiterate | Buy |
| 2022-12-19 | EF Hutton | Initiate | Buy |
| 2022-12-15 | HC Wainwright & Co. | Initiate | Buy |
| 2021-12-22 | Oppenheimer | Initiate | Outperform |
| 2021-12-21 | Oppenheimer | Initiate | Outperform |